case report
The existence of CD19-negative immature B cells complicated the evaluation of residual disease in a case after chimeric antigen receptor (CAR)-T cell therapy for B-lymphoblastic leukemia
Noriyuki Okubo, Shizue Ishizuka, Akifumi Mayama, Sho Yoshioka, Natsumi Shimizu, Chie Suzuki, Shingo Sugawara, Masahiro Irie, Saori Katayama, Hiroki Kato, Takashi Kamei
Author information
Keywords:
CD19 antigen,
chimeric antigen receptor T cell,
B-lymphoblastic leukemia,
measurable residual disease,
flow cytometry
2025 Volume 35 Issue 1 Pages 33-35
Details
